Cargando…

The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol

BACKGROUND: Although Dialectical Behaviour Therapy (DBT) is an evidence-based psychosocial treatment for borderline personality disorder (BPD), the demand for it exceeds available resources. The commonly researched 12-month version of DBT is lengthy; this can pose a barrier to its adoption in many h...

Descripción completa

Detalles Bibliográficos
Autores principales: McMain, Shelley F., Chapman, Alexander L., Kuo, Janice R., Guimond, Tim, Streiner, David L., Dixon-Gordon, Katherine L., Isaranuwatchai, Wanrudee, Hoch, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050694/
https://www.ncbi.nlm.nih.gov/pubmed/30016935
http://dx.doi.org/10.1186/s12888-018-1802-z
_version_ 1783340391275167744
author McMain, Shelley F.
Chapman, Alexander L.
Kuo, Janice R.
Guimond, Tim
Streiner, David L.
Dixon-Gordon, Katherine L.
Isaranuwatchai, Wanrudee
Hoch, Jeffrey S.
author_facet McMain, Shelley F.
Chapman, Alexander L.
Kuo, Janice R.
Guimond, Tim
Streiner, David L.
Dixon-Gordon, Katherine L.
Isaranuwatchai, Wanrudee
Hoch, Jeffrey S.
author_sort McMain, Shelley F.
collection PubMed
description BACKGROUND: Although Dialectical Behaviour Therapy (DBT) is an evidence-based psychosocial treatment for borderline personality disorder (BPD), the demand for it exceeds available resources. The commonly researched 12-month version of DBT is lengthy; this can pose a barrier to its adoption in many health care settings. Further, there are no data on the optimal length of psychotherapy for BPD. The aim of this study is to examine the clinical and cost-effectiveness of 6 versus 12 months of DBT for chronically suicidal individuals with BPD. A second aim of this study is to determine which patients are as likely to benefit from shorter treatment as from longer treatment. METHODS/DESIGN: Powered for non-inferiority testing, this two-site single-blind trial involves the random assignment of 240 patients diagnosed with BPD to 6 or 12 months of standard DBT. The primary outcome is the frequency of suicidal or non-suicidal self-injurious episodes. Secondary outcomes include healthcare utilization, psychiatric and emotional symptoms, general and social functioning, and health status. Cost-effectiveness outcomes will include the cost of providing each treatment as well as health care and societal costs (e.g., missed work days and lost productivity). Assessments are scheduled at pretreatment and at 3-month intervals until 24 months. DISCUSSION: This is the first study to directly examine the dose-effect of psychotherapy for chronically suicidal individuals diagnosed with BPD. Examining both clinical and cost effectiveness in 6 versus 12 months of DBT will produce answers to the question of how much treatment is good enough. Information from this study will help to guide decisions about the allocation of scarce treatment resources and recommendations about the benefits of briefer treatment. TRIAL REGISTRATION: NCT02387736. Registered February 20, 2015.
format Online
Article
Text
id pubmed-6050694
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60506942018-07-19 The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol McMain, Shelley F. Chapman, Alexander L. Kuo, Janice R. Guimond, Tim Streiner, David L. Dixon-Gordon, Katherine L. Isaranuwatchai, Wanrudee Hoch, Jeffrey S. BMC Psychiatry Study Protocol BACKGROUND: Although Dialectical Behaviour Therapy (DBT) is an evidence-based psychosocial treatment for borderline personality disorder (BPD), the demand for it exceeds available resources. The commonly researched 12-month version of DBT is lengthy; this can pose a barrier to its adoption in many health care settings. Further, there are no data on the optimal length of psychotherapy for BPD. The aim of this study is to examine the clinical and cost-effectiveness of 6 versus 12 months of DBT for chronically suicidal individuals with BPD. A second aim of this study is to determine which patients are as likely to benefit from shorter treatment as from longer treatment. METHODS/DESIGN: Powered for non-inferiority testing, this two-site single-blind trial involves the random assignment of 240 patients diagnosed with BPD to 6 or 12 months of standard DBT. The primary outcome is the frequency of suicidal or non-suicidal self-injurious episodes. Secondary outcomes include healthcare utilization, psychiatric and emotional symptoms, general and social functioning, and health status. Cost-effectiveness outcomes will include the cost of providing each treatment as well as health care and societal costs (e.g., missed work days and lost productivity). Assessments are scheduled at pretreatment and at 3-month intervals until 24 months. DISCUSSION: This is the first study to directly examine the dose-effect of psychotherapy for chronically suicidal individuals diagnosed with BPD. Examining both clinical and cost effectiveness in 6 versus 12 months of DBT will produce answers to the question of how much treatment is good enough. Information from this study will help to guide decisions about the allocation of scarce treatment resources and recommendations about the benefits of briefer treatment. TRIAL REGISTRATION: NCT02387736. Registered February 20, 2015. BioMed Central 2018-07-17 /pmc/articles/PMC6050694/ /pubmed/30016935 http://dx.doi.org/10.1186/s12888-018-1802-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
McMain, Shelley F.
Chapman, Alexander L.
Kuo, Janice R.
Guimond, Tim
Streiner, David L.
Dixon-Gordon, Katherine L.
Isaranuwatchai, Wanrudee
Hoch, Jeffrey S.
The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol
title The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol
title_full The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol
title_fullStr The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol
title_full_unstemmed The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol
title_short The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol
title_sort effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (faster) trial protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050694/
https://www.ncbi.nlm.nih.gov/pubmed/30016935
http://dx.doi.org/10.1186/s12888-018-1802-z
work_keys_str_mv AT mcmainshelleyf theeffectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT chapmanalexanderl theeffectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT kuojanicer theeffectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT guimondtim theeffectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT streinerdavidl theeffectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT dixongordonkatherinel theeffectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT isaranuwatchaiwanrudee theeffectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT hochjeffreys theeffectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT mcmainshelleyf effectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT chapmanalexanderl effectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT kuojanicer effectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT guimondtim effectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT streinerdavidl effectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT dixongordonkatherinel effectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT isaranuwatchaiwanrudee effectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol
AT hochjeffreys effectivenessof6versus12monthsofdialecticalbehaviourtherapyforborderlinepersonalitydisorderthefeasibilityofashortertreatmentandevaluatingresponsesfastertrialprotocol